U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C12H16N4O3
Molecular Weight 264.2804
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of IPRAZOCHROME

SMILES

CC(C)N1CC(O)C2=C\C(=N\NC(N)=O)C(=O)C=C12

InChI

InChIKey=XZKVIDLLLOUTSS-ZSOIEALJSA-N
InChI=1S/C12H16N4O3/c1-6(2)16-5-11(18)7-3-8(14-15-12(13)19)10(17)4-9(7)16/h3-4,6,11,18H,5H2,1-2H3,(H3,13,15,19)/b14-8-

HIDE SMILES / InChI

Molecular Formula C12H16N4O3
Molecular Weight 264.2804
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 1
Optical Activity ( + / - )

Description

Iprazochrome is a serotonin antagonist both in vitro and in vivo. It is used in the prophylaxis of migraine and in the treatment of diabetic retinopathy.

CNS Activity

Approval Year

Sample Use Guides

In Vivo Use Guide
In adults, the usual dose is 1 - 2 (maximum 3) tablets of Divascan (Iprazochrome 2.5 mg) 3 times a day.
Route of Administration: Oral
Substance Class Chemical
Record UNII
903A9K181P
Record Status Validated (UNII)
Record Version